Physician profile
Joel Abramowitz
NPI 1356429377
$1,167.61
in general payments reported to CMS, 2019-2025
10 companies · $188 in 2025
The $188 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $803 · 2020: $11.50 · 2022: $51.59 · 2023: $91.35 · 2024: $22.66 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $301.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $531.24 | 2019 | |
| Pfizer INC. | $226.87 | 2019-2020 | |
| Kerecis Limited | $187.57 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Bayer Healthcare Pharmaceuticals INC. | $94.61 | 2022-2024 | |
| Astellas Pharma US INC | $43.08 | 2019 | |
| Myovant Sciences INC. | $26.03 | 2022 | |
| Tolmar, INC. | $16.10 | 2023 | |
| Sumitomo Pharma America, INC. | $14.46 | 2023 | Orgovyx |
| Telix Pharmaceuticals | $14.40 | 2023 | Illuccix |
| Tolmar Pharmaceuticals, INC. | $13.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Abramowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.